The anti-proliferative activity of interferon-γ on ovarian cancer:: In vitro and in vivo

被引:29
作者
Wall, L [1 ]
Burke, F
Smyth, JF
Balkwill, F
机构
[1] Western Gen Hosp, Imperial Canc Res Fund, Med Oncol Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Imperial Canc Res Fund, Translat Oncol Lab, London, England
[3] Royal London Sch Med & Dent, London, England
关键词
D O I
10.1006/gyno.2002.6707
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:S149 / S151
页数:3
相关论文
共 21 条
[1]  
ALLAVENA P, 1990, CANCER RES, V50, P7318
[2]   Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA [J].
Burke, F ;
Smith, PD ;
Crompton, MR ;
Upton, C ;
Balkwill, FR .
BRITISH JOURNAL OF CANCER, 1999, 80 (08) :1236-1244
[3]   Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat [J].
Burke, F ;
East, N ;
Upton, C ;
Patel, K ;
Balkwill, FR .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) :1114-1121
[4]  
Chen CK, 1999, J FORMOS MED ASSOC, V98, P24
[5]   EFFECT OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA ON SENSITIVITY TO CISPLATIN IN OVARIAN-CARCINOMA CELL-LINES [J].
CLARK, S ;
MCGUCKIN, MA ;
HURST, T ;
WARD, BG .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (02) :100-104
[6]   ANTITUMOR AND IMMUNOMODULATORY ACTIVITY OF INTRAPERITONEAL IFN-GAMMA IN OVARIAN-CARCINOMA PATIENTS WITH MINIMAL RESIDUAL TUMOR AFTER CHEMOTHERAPY [J].
COLOMBO, N ;
PECCATORI, F ;
PAGANIN, C ;
BINI, S ;
BRANDELY, M ;
MANGIONI, C ;
MANTOVANI, A ;
ALLAVENA, P .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (01) :42-46
[7]   A PHASE-I TRIAL OF INTRAPERITONEAL RECOMBINANT GAMMA-INTERFERON IN ADVANCED OVARIAN-CARCINOMA [J].
DACQUISTO, R ;
MARKMAN, M ;
HAKES, T ;
RUBIN, S ;
HOSKINS, W ;
LEWIS, JL .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) :689-695
[8]  
MALIK STA, 1991, CANCER RES, V51, P6643
[9]  
Marth C, 1996, INT J CANCER, V67, P826, DOI 10.1002/(SICI)1097-0215(19960917)67:6<826::AID-IJC12>3.0.CO
[10]  
2-#